UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Universe Pharmaceuticals INC
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026
$3.76−0.17 (-4.33%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Universe Pharmaceuticals has not reported a dividend
No dividend per share appears in Universe Pharmaceuticals's annual filings since fiscal 2018.